Episode 078: Management of relapsed diffuse large B-cell lymphoma (DLBCL) - Part 2
The Fellow on Call: The Heme/Onc Podcast
00:00
Exploring Combination Therapies in Relapsed DLBCL
This chapter examines the clinical findings of the tafacitimab and lenalidomide combination therapy for relapsed diffuse large B-cell lymphoma. It highlights the promising results from the L-MIND study, including overall response rates and the efficacy of this approach compared to other treatments.
Transcript
Play full episode
